Vyzulta Solution/ Drops
Product Images NDC 24208-504

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vyzulta (NDC 24208-504). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton 2.5ml.jpg.jpg

Packaging label for Vyzulta (latanoprostene bunod ophthalmic solution) 0.024%, 2.5 mL sterile drops by Bausch & Lomb Incorporated. The label includes active and inactive ingredients, storage instructions, and usage information, indicating it is for topical ophthalmic use and prescription only.*

FDA Label Image

Carton 5ml

Packaging label for Vyzulta (latanoprostene bunod ophthalmic solution) 0.024%, an ophthalmic solution in a 5 mL bottle. The label shows the product name, active ingredient, strength, and usage as topical ophthalmic drops. It is labeled as sterile and Rx only. The manufacturer and distributor is Bausch & Lomb Incorporated. The label includes storage instructions, inactive ingredients, preservatives, and barcode information.*

FDA Label Image

Figure 1 (Image 01)

Chemical structure of latanoprostene bunod, the active ingredient in Vyzulta ophthalmic solution 0.24 mg/mL by Bausch & Lomb Incorporated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.